AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28728924 — intervention group
Group type: EXPERIMENTAL
Intervention: Strabismus video goggles
Number of subjects: 41
Study 28728924 — intervention group
Group type: COMPARATOR
Intervention: Hess screen test
Number of subjects: 41
Study 28729326 — intervention group
Group type: EXPERIMENTAL
Intervention: CSDD (Cornell Scale for Depression in Dementia)
Number of subjects: 170
Study 28729326 — intervention group
Group type: EXPERIMENTAL
Intervention: BBS (Berg Balance Scale)
Number of subjects: 170
Study 28729326 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 s CST (Chair Stand Test)
Number of subjects: 170
Study 28729326 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking speed (6-metre walking test)
Number of subjects: 170
Study 28729911 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (VP)
Number of subjects: 140
Study 28729911 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 140
Study 28730692 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-sex hormone therapy (CSHT) for trans men
Number of subjects: 183
Study 28730692 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-sex hormone therapy (CSHT) for trans women
Number of subjects: 183
Study 28730932 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-lumen tube (SLT)
Number of subjects: 92
Study 28730932 — intervention group
Group type: COMPARATOR
Intervention: Double-lumen tube (DLT)
Number of subjects: 92
Study 28731937 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative management
Number of subjects: 484
Study 28731937 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative management
Number of subjects: 484
Study 28732391 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraductal radiofrequency ablation device
Number of subjects: 0
Study 28732501 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak CO exposure (≥4.1 ppm) in the 2 hours prior to BP measurement
Number of subjects: 44
Study 28732501 — intervention group
Group type: COMPARATOR
Intervention: Improved cookstoves
Number of subjects: 44
Study 28732501 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-h ABPM sessions
Number of subjects: 44
Study 28733294 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (specific details not provided)
Number of subjects: 0
Study 28733294 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational data collection (specific details not provided)
Number of subjects: 0
Study 28733294 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbiological tests (specific details not provided)
Number of subjects: 0
Study 28733943 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA injections (70 to 150 U per session, targeted to pericranial myofascial sites)
Number of subjects: 63
Study 28733943 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA injections
Number of subjects: 63
Study 28734628 — intervention group
Group type: EXPERIMENTAL
Intervention: ADRA2A_2790CC genotype
Number of subjects: 351
Study 28734628 — intervention group
Group type: COMPARATOR
Intervention: CT/TT genotypes
Number of subjects: 351
Study 28734628 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-Norwood complications
Number of subjects: 351
Study 28734829 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral salpingectomy during vaginal hysterectomy
Number of subjects: 74
Study 28735291 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of low coronary artery calcium score and low high-sensitivity cardiac troponin T
Number of subjects: 532
Study 28735291 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower high-sensitivity cardiac troponin T and coronary artery calcium
Number of subjects: 532
Study 28735759 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth loss levels (measured as number of teeth: 26-32, 20-25, 15-19, 1-14, No Teeth)
Number of subjects: 15456
Study 28736110 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile autoregulated artificial heart
Number of subjects: 0
Study 28736110 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 28736443 — intervention group
Group type: EXPERIMENTAL
Intervention: CLOCK 3111C carriers (CC and TC)
Number of subjects: 40
Study 28736443 — intervention group
Group type: COMPARATOR
Intervention: TT carriers
Number of subjects: 40
Study 28736443 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss during treatment program
Number of subjects: 40
Study 28736443 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmicity-weight loss associations
Number of subjects: 40
Study 28736545 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy
Number of subjects: 15
Study 28736545 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 15
Study 28736819 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal therapy
Number of subjects: 20
Study 28736819 — intervention group
Group type: COMPARATOR
Intervention: Control group (clinically healthy individuals)
Number of subjects: 20
Study 28738781 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Magnetic Resonance (CMR) imaging technique
Number of subjects: 150
Study 28738781 — intervention group
Group type: COMPARATOR
Intervention: CMR imaging
Number of subjects: 150
Study 28738781 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary arteries evaluated by computed tomography angiography
Number of subjects: 150
Study 28738781 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaires for Quality-of-Life (QoL)
Number of subjects: 150
Study 28738791 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthropometric indices (BMI, height, weight)
Number of subjects: 7268
Study 28738791 — intervention group
Group type: EXPERIMENTAL
Intervention: Percent stunted (<-2SD height for age z-score)
Number of subjects: 7268
Study 28738791 — intervention group
Group type: EXPERIMENTAL
Intervention: % underweight (BMI <18.5)
Number of subjects: 7268
Study 28738791 — intervention group
Group type: EXPERIMENTAL
Intervention: % overweight/obese (BMI ≥25.0)
Number of subjects: 7268
Study 28738791 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic status (SES) and age correlation with BMI
Number of subjects: 7268
Study 28738791 — intervention group
Group type: EXPERIMENTAL
Intervention: Age correlation with weight status
Number of subjects: 7268
Study 28738797 — intervention group
Group type: EXPERIMENTAL
Intervention: TTC arthrodesis with reverse PHILOS plate and medial cannulated screw
Number of subjects: 12
Study 28738902 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Self-Management Support Empowerment Model
Number of subjects: 240
Study 28738902 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Care Model
Number of subjects: 240
Study 28739783 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin (600 mg, once daily)
Number of subjects: 15
Study 28740058 — intervention group
Group type: EXPERIMENTAL
Intervention: No-cutpoint networks
Number of subjects: 1384
Study 28740058 — intervention group
Group type: EXPERIMENTAL
Intervention: Only-family networks
Number of subjects: 1384
Study 28740058 — intervention group
Group type: EXPERIMENTAL
Intervention: Network size
Number of subjects: 1384
Study 28740058 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 1384
Study 28740367 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive lifestyle changes and/or metformin treatment
Number of subjects: 0
Study 28740367 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 28740411 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealthcare intervention for patients with COPD
Number of subjects: 1225
Study 28740411 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealthcare intervention for patients younger than 60 years
Number of subjects: 1225
Study 28740411 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analyses across various factors (comorbidities, age-groups, genders, resource patterns, delivery sites)
Number of subjects: 1225
Study 28740869 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-genome sequencing (WGS) and RNA sequencing (RNA-seq)
Number of subjects: 0
Study 28740869 — intervention group
Group type: EXPERIMENTAL
Intervention: IBM Watson Genomic Analytics (WGA)
Number of subjects: 0
Study 28741071 — intervention group
Group type: EXPERIMENTAL
Intervention: lanreotide depot/autogel (LAN)
Number of subjects: 241
Study 28742292 — intervention group
Group type: EXPERIMENTAL
Intervention: Right unilateral ultrabrief pulse ECT combined with venlafaxine
Number of subjects: 240
Study 28742709 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared cholangiography (NIR-C)
Number of subjects: 58
Study 28742709 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional virtual reality (VR)
Number of subjects: 58
Study 28742709 — intervention group
Group type: EXPERIMENTAL
Intervention: X-ray intraoperative cholangiography (IOC)
Number of subjects: 58
Study 28743102 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium screening using the Intensive Care Delirium Screening Checklist or the Confusion Assessment Method for the Intensive Care Unit
Number of subjects: 0
Study 28743198 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 50
Study 28743198 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 50
Study 28743198 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation Therapy (RT)
Number of subjects: 50
Study 28743198 — intervention group
Group type: COMPARATOR
Intervention: Overall Results
Number of subjects: 50
Study 28743681 — intervention group
Group type: EXPERIMENTAL
Intervention: Intelligent Pain Management System (IPMS)
Number of subjects: 46
Study 28743681 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods (control group)
Number of subjects: 46
Study 28743683 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers of conventional cigarettes
Number of subjects: 900
Study 28743683 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex-smokers (quit smoking 1 to 5 years ago)
Number of subjects: 900
Study 28743683 — intervention group
Group type: EXPERIMENTAL
Intervention: Never-smokers
Number of subjects: 900
Study 28744217 — intervention group
Group type: EXPERIMENTAL
Intervention: Busulfan-cyclophosphamide (BU-CY) conditioning regimen
Number of subjects: 72
Study 28744217 — intervention group
Group type: EXPERIMENTAL
Intervention: Univariate analysis of HC incidence
Number of subjects: 72
Study 28744244 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Teacher Program targeting ADHD symptoms
Number of subjects: 0
Study 28744716 — intervention group
Group type: EXPERIMENTAL
Intervention: Colorectal cancer screening via fecal testing
Number of subjects: 0
Study 28744716 — intervention group
Group type: EXPERIMENTAL
Intervention: Colorectal cancer screening via colonoscopy
Number of subjects: 0
Study 28744716 — intervention group
Group type: EXPERIMENTAL
Intervention: Colorectal cancer screening overall
Number of subjects: 0
Study 28745646 — intervention group
Group type: EXPERIMENTAL
Intervention: Sternberg Working Memory paradigm during threat of shock
Number of subjects: 0
Study 28745646 — intervention group
Group type: COMPARATOR
Intervention: Threat of shock condition
Number of subjects: 0
Study 28745646 — intervention group
Group type: COMPARATOR
Intervention: Safe condition
Number of subjects: 0
Study 28746812 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells (AD MSCs)
Number of subjects: 18
Study 28747021 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically managed NSTE-ACS patients
Number of subjects: 2272
Study 28747021 — intervention group
Group type: EXPERIMENTAL
Intervention: CAG- group
Number of subjects: 2272
Study 28747021 — intervention group
Group type: EXPERIMENTAL
Intervention: CAG+ CAD- group
Number of subjects: 2272
Study 28747021 — intervention group
Group type: EXPERIMENTAL
Intervention: CAG+ CAD+ group
Number of subjects: 2272
Study 28747274 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand PrEP (tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg) taken before and after sexual intercourse
Number of subjects: 361
Study 28747274 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand PrEP
Number of subjects: 361
Study 28747397 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with STEMI
Number of subjects: 11
Study 28747397 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 11
Study 28747452 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-guided focused ultrasound thalamotomy (MRgFUS) targeting the ventro-intermedius nucleus (Vim) of the dominant hemisphere
Number of subjects: 6
Study 28747857 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted cessation intervention (treatment arm) with nicotine patches for 8 weeks
Number of subjects: 97
Study 28747857 — intervention group
Group type: COMPARATOR
Intervention: Standard cognitive behavioral therapy (comparison arm) with nicotine patches for 8 weeks
Number of subjects: 97
Study 28748214 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-exome sequencing
Number of subjects: 1
Study 28750271 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2780301 500 mg QD plus gemcitabine 750 mg/m²
Number of subjects: 50
Study 28750271 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2780301 400 mg QD plus gemcitabine 1000 mg/m²
Number of subjects: 50
Study 28750271 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2780301 500 mg QD plus gemcitabine 1000 mg/m²
Number of subjects: 50
Study 28750271 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2780301 400 mg QD plus gemcitabine 750 mg/m²
Number of subjects: 50
Study 28750429 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-treated patients with diabetes
Number of subjects: 2430
Study 28750603 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitts' Reciprocal Aiming Task v.1.0 (Horizontal) with smaller targets
Number of subjects: 48
Study 28750603 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitts' Reciprocal Aiming Task v.1.0 (Horizontal) with speed demands
Number of subjects: 48
Study 28750603 — intervention group
Group type: COMPARATOR
Intervention: Comparison of CP group to typical development (TD) group
Number of subjects: 48
Study 28750608 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 469
Study 28750608 — intervention group
Group type: COMPARATOR
Intervention: Anti-arrhythmic drug therapy
Number of subjects: 469
Study 28750642 — intervention group
Group type: EXPERIMENTAL
Intervention: CMR fluoroscopy guided right heart catheterization (RHC)
Number of subjects: 102
Study 28750659 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 cycles of modified FOLFIRINOX (oxaliplatin 85 mg/m2, details of other drugs not provided)
Number of subjects: 134
Study 28750659 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy plus hypofractionated radiation therapy
Number of subjects: 134
Study 28750671 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid analysis
Number of subjects: 24
Study 28750671 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood analysis
Number of subjects: 24
Study 28750697 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature-controlled irrigated RF catheter (DiamondTemp)
Number of subjects: 70
Study 28750697 — intervention group
Group type: COMPARATOR
Intervention: Standard force-sensing catheter (control)
Number of subjects: 70
Study 28751001 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID
Number of subjects: 0
Study 28751001 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 0
Study 28751001 — intervention group
Group type: COMPARATOR
Intervention: Placebo BID
Number of subjects: 0
Study 28751001 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 or 10 mg BID
Number of subjects: 0
Study 28751088 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoalbuminemia group (Hypo-AG, serum albumin <28 g/L)
Number of subjects: 426
Study 28751088 — intervention group
Group type: EXPERIMENTAL
Intervention: Marginal hypoalbuminemia group (Margin-AG, serum albumin 28-34.9 g/L)
Number of subjects: 426
Study 28751088 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal albuminemia group (Normal-AG, serum albumin ≥35 g/L)
Number of subjects: 426
Study 28751125 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth with Down syndrome (DS)
Number of subjects: 0
Study 28751125 — intervention group
Group type: COMPARATOR
Intervention: Youth without Down syndrome (non-DS)
Number of subjects: 0
Study 28751125 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth without DS with obesity
Number of subjects: 0
Study 28751125 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth with DS with obesity
Number of subjects: 0
Study 28751125 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers of youth with DS
Number of subjects: 0
Study 28751125 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers of youth with obesity (regardless of DS status)
Number of subjects: 0
Study 28751247 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib (80 or 160 mg daily)
Number of subjects: 61
Study 28751558 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 1505
Study 28751559 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-of-function mutations of IKZF1
Number of subjects: 0
Study 28751559 — intervention group
Group type: EXPERIMENTAL
Intervention: Dominant-negative mutations of IKZF1
Number of subjects: 0
Study 28751763 — intervention group
Group type: EXPERIMENTAL
Intervention: Four or more risk factors
Number of subjects: 858
Study 28751763 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal pre-pregnancy overweight status
Number of subjects: 858
Study 28751763 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal overweight status
Number of subjects: 858
Study 28752370 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA and diclofenac
Number of subjects: 58
Study 28752370 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 58
Study 28752679 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of autologous stimulated bone marrow stem cells (BM-SC)
Number of subjects: 61
Study 28752679 — intervention group
Group type: COMPARATOR
Intervention: Oral acetaminophen (Control group)
Number of subjects: 61
Study 28752805 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 PUFAs supplementation (1800 mg daily for 12 weeks, containing 1206 mg eicosapentaenoic acid and 609 mg docosahexaenoic acid)
Number of subjects: 13
Study 28753486 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10mg/day
Number of subjects: 1403
Study 28753486 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25mg/day
Number of subjects: 1403
Study 28753486 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (both doses)
Number of subjects: 1403
Study 28753747 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix therapy for 7 months
Number of subjects: 191
Study 28753747 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced two-factor model (baseline PSA, age)
Number of subjects: 191
Study 28753747 — intervention group
Group type: EXPERIMENTAL
Intervention: End of induction period (EOI) PSA
Number of subjects: 191
Study 28753747 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone recovery
Number of subjects: 191
Study 28754178 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser speckle contrast imaging combined with skin iontophoresis of acetylcholine (endothelium-dependent vasodilator)
Number of subjects: 0
Study 28754178 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser speckle contrast imaging combined with skin iontophoresis of sodium nitroprusside (endothelium-independent vasodilator)
Number of subjects: 0
Study 28754178 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional capillary density assessment by video-microscopy
Number of subjects: 0
Study 28754178 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-occlusive reactive hyperemia
Number of subjects: 0
Study 28754178 — intervention group
Group type: COMPARATOR
Intervention: Control group of sex- and age-matched healthy volunteers
Number of subjects: 0
Study 28754476 — intervention group
Group type: EXPERIMENTAL
Intervention: Designated women's health provider
Number of subjects: 281
Study 28754476 — intervention group
Group type: EXPERIMENTAL
Intervention: Stronger self-efficacy beliefs about screening women for MST
Number of subjects: 281
Study 28754476 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeing women patients at least once per week
Number of subjects: 281
Study 28754476 — intervention group
Group type: EXPERIMENTAL
Intervention: Stronger self-efficacy beliefs about screening women for IPV
Number of subjects: 281
Study 28754494 — intervention group
Group type: EXPERIMENTAL
Intervention: CV7201 (mRNA rabies vaccine) administered intradermally or intramuscularly by needle-syringe or needle-free devices, doses ranging from 80-640 μg, with three doses and a booster after 1 year.
Number of subjects: 101
Study 28754494 — intervention group
Group type: EXPERIMENTAL
Intervention: CV7201 (mRNA rabies vaccine) administered intradermally or intramuscularly, doses of 80 μg or 160 μg intradermally and 200 μg or 400 μg intramuscularly.
Number of subjects: 101
Study 28754494 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster dose of 80 μg CV7201 administered needle-free intradermally after 1 year.
Number of subjects: 101
Study 28754494 — intervention group
Group type: COMPARATOR
Intervention: Intradermal or intramuscular needle-syringe injection of CV7201.
Number of subjects: 101
Study 28754534 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting beads loaded with doxorubicin (DEBDOX)
Number of subjects: 20
Study 28754808 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 9012
Study 28754808 — intervention group
Group type: COMPARATOR
Intervention: Men
Number of subjects: 9012
Study 28754808 — intervention group
Group type: EXPERIMENTAL
Intervention: Women (after adjustment)
Number of subjects: 9012
Study 28754833 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolichoectasia
Number of subjects: 3850
Study 28755137 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate 100 µG once daily
Number of subjects: 0
Study 28755137 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate 250 µG twice daily
Number of subjects: 0
Study 28755256 — intervention group
Group type: EXPERIMENTAL
Intervention: Local excision for patients with mCR
Number of subjects: 0